Pharmacy PrEP Education
A “How To” Series Spanning Policy to Practice
Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.
Baeten JM, et al. N Engl J Med. 2012;367(5):399-410.
Stigma, medical mistrust, and perceived racism may affect PrEP awareness and uptake in black compared to white gay and bisexual men in Jackson, Mississippi and Boston, Massachusetts.
Cahill S, et al. AIDS Care. 2017;29(11):1351-1358.
Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial.
Choopanya K, et al. Lancet. 2013;381(9883):2083-2090.
Assessing the efficacy and feasibility of a retail pharmacy-based HIV testing program.
Collins BC, et al. 24th Conference on Retroviruses and Opportunistic Infections (CROI) 2017; February 13-17, 2017; Seattle, WA. Abstract 962.
Community pharmacy delivered PrEP to STOP HIV transmission: an opportunity NOT to miss!
Lopez MI, et al. J Am Pharm Assoc (2003). 2020;60(4):e18-e24.
Why don't patients take their drugs? The role of communication, context and culture in patient adherence and the work of the pharmacist in HIV/AIDS.
Penn C, et al. Patient Educ Couns. 2011;83(3):310-318.
4 findings from a successful HIV PrEP program.
Ross M. Pharm Times. 2016-01-07;15:30:00.
Truvada: emtricitabine/tenofovir disoproxil.
European Medicines Agency (EMA). 2021.
Emtricitabine/tenofovir alafenamide.
HIV.gov. Drug database.
Emtricitabine/tenofovir disoproxil fumarate.
HIV.gov. Drug database.
Cabotegravir.
HIV.gov. Drug database.
Being PrEPared—preexposure prophylaxis and HIV disparities.
Goldstein RH, et al. N Engl J Med. 2018;379(14):1293-1295.
Lifetime risk of a diagnosis of HIV infection in the United States.
Hess KL, et al. Ann Epidemiol. 2017;27(4):238-243.
Cabotegravir for HIV prevention in cisgender men and transgender women.
Landovitz RJ, et al. N Engl J Med. 2021;385(7):595-608.
Emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis (DISCOVER): primary results from a randomised, double-blind, multicentre, active-controlled, phase 3, non-inferiority trial.
Mayer KH, et al. Lancet. 2020;396(10246):239-254.
Implementation of a community pharmacy-based pre-exposure prophylaxis service: a novel model for pre-exposure prophylaxis care.
Tung EL, et al. Sex Health. 2018;15(6):556-561.
HIV testing in community pharmacies and retail clinics: a model to expand access to screening for HIV infection.
Weidle PJ, et al. J Am Pharm Assoc. 2014; 54(5):486-492.
PrEP Pharmacy Monograph and State-Supplements
Providing PEP/PrEP in the Pharmacy Setting: A Comprehensive User Guide
Are you seeking specific insights and suggestions as you prepare to implement postexposure prophylaxis (PEP) and preexposure prophylaxis (PrEP) in your pharmacy practice? This activity qualifies participants for 2.0 CPE credits to fulfill State Board of Pharmacy training requirements
Calling all pharmacists from: Nevada, Oregon, and Virginia!
Your Board of Pharmacy has recently expanded your scope of practice to include prescribing and dispensing of PrEP and PEP. Learn the details specific to your state with these short primers:
- Providing PrEP in the Pharmacy Setting: Nevada Edition
- Providing PrEP in the Pharmacy Setting: Oregon Edition
- Providing PrEP in the Pharmacy Setting: Virginia Edition
CLINICAL PRACTICE GUIDELINES
Preexposure prophylaxis for the prevention of HIV infection in the United States—2021 update. A clinical practice guideline.
US Public Health Service. Centers for Disease Control and Prevention; 2021.
Sexually transmitted infections treatment guidelines, 2021.
Centers for Disease Control and Prevention. Last reviewed July 2021.
Updated guidelines for antiretroviral postexposure prophylaxis after sexual, injection drug use, or other nonoccupational exposure to HIV—United States, 2016.
CDC Stacks. Centers for Disease Control and Prevention; last updated May 2018.
The Fenway Guide to Lesbian, Gay, Bisexual, and Transgender Health.
Makadon HJ, et al, American College of Physicians (ACP), eds. 2nd ed. Boston, MA: Fenway Health; 2015.
Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2020 recommendations of the International Antiviral Society—USA Panel.
Saag MS, et al. JAMA. 2020;324(16):1651-1669.
ASHP [American Society of Health-System Pharmacists] guidelines on pharmacist involvement in HIV care.
Schafer JJ, et al. Am J Health Syst Pharm. 2016;73(7):468-494.
Guidelines for the use of antiretroviral agents in adults and adolescents living with HIV.
US Department of Health and Human Services; last updated January 2022.
PROFESSIONAL ORGANIZATIONS & RESOURCES
American Academy of HIV Medicine.
AIDS Education & Training Center (AETC) Program: National Coordinating Resource Center
Provides consultation, training, and resources nationwide.
A guide to taking a sexual history.
Centers for Disease Control and Prevention. 2022.
Basic statistics.
Centers for Disease Control and Prevention; updated April 2022.
HIV testing.
Centers for Disease Control and Prevention; June 2022.
HIV testing in retail pharmacies (training for pharmacists and pharmacy staff).
Centers for Disease Control and Prevention; Updated 2022.
Taking Routine Histories of Sexual Health: A System-Wide Approach for Health Centers.
National LGBTQIA+ Health Education Center. 2016.
Ending the HIV epidemic: Ready, Set, PrEP!
US Department of Health and Human Services.
Please PrEP Me
Both professional and patient resources as well as a state-by-state list of PrEP resources in all 50 states.
Preexposure prophylaxis for the prevention of HIV infection in the United States—2021 update. Clinical providers’ supplement.
US Public Health Service. Centers for Disease Control and Prevention; 2021.
National Clinician Consultation Center.
University of California, San Francisco; 2020.
HIV drug interactions.
University of Liverpool (website); updated July 2022.
Sexual History Taking Toolkit.
TargetHIV. 2022.
PATIENT RESOURCES
HIV basics.
Centers for Disease Control and Prevention; April 2021.
Prevention for women. Resources on HIV prevention for U.S. women.
HIVE online; 2019.
HIV resources.
National Institutes of Health; September 2020.
Positively Aware.
Positively Aware, created by TPAN (Test Positive Aware Network), is a source of HIV-treatment news for consumers, as well as an educational tool for HIV caregivers. The site features PrEP resources, including videos for men who have sex with men and transgender people.
UCSF transgender care.
University of California, San Francisco; 2019.
Optimizing PrEP Access Through Advocacy
Pharmacy PrEP Education: A “How To” Series Spanning Policy to Practice
| Faculty: | Melissa Badowski, PharmD, MPH, and Scott Bertani, MA |
| Release: | 06/28/2022 |
| Expiration: | 06/28/2023 |
Providing PEP/PrEP in the Pharmacy Setting - Nevada Edition
Pharmacy PrEP Education: A “How-to” Series Spanning Policy to Practice
| Faculty: | Christina M. Madison, PharmD, FCCP, AAHIVP |
| Release: | 07/29/2022 |
| Expiration: | 07/29/2023 |
Providing PEP/PrEP in the Pharmacy Setting - Oregon Edition
Pharmacy PrEP Education: A “How-to” Series Spanning Policy to Practice
| Faculty: | Arsalan Shah, PharmD, MBA |
| Release: | 07/29/2022 |
| Expiration: | 07/29/2023 |
Providing PEP/PrEP in the Pharmacy Setting - Virginia Edition
Pharmacy PrEP Education: A “How-to” Series Spanning Policy to Practice
| Faculty: | Jonathan Frochtzwajg |
| Release: | 07/29/2022 |
| Expiration: | 07/29/2023 |
Providing PEP/PrEP in the Pharmacy Setting: A Comprehensive User Guide
Pharmacy PrEP Education: A “How-to” Series Spanning Policy to Practice
| Faculty: | Melissa Badowski, PharmD, MPH, FCCP, FIDSA, BCIDP, BCPS, AAHIVP & Shauna Applin, A-NP, AAHIVs |
| Release: | 07/29/2022 |
| Expiration: | 07/29/2023 |
